MOLECULAR IMAGING CONSULTING & MANAGEMENT LTD

Active
Company number 09938675Private limited companyIncorporated 2016

Key figures

£100+100.0%
Net assets 2024/25
-84.9%
Average annual change 2020/21–2024/25
-750 k-500 k-250 k0250 k2020/212021/222022/232023/242024/25

Like most small UK companies, MOLECULAR IMAGING CONSULTING & MANAGEMENT LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Sector comparison

SIC 82990

Where the company stands among the 160,475 active companies whose first SIC code is 82990 (Other business support service activities n.e.c.).

Company age10.8 years
Older than 53% · median 10.2 years

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant. The line on each bar marks the median.

Summary: MOLECULAR IMAGING CONSULTING & MANAGEMENT LTD

What kind of company is it?

MOLECULAR IMAGING CONSULTING & MANAGEMENT LTD is a private limited company registered with Companies House under company number 09938675. It was incorporated on 6 Jan 2016. Its status is active. The registered office is in London (N1). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

How is the company doing financially?

The latest accounts in the database are for 2024/25 (period ending 23 Mar 2025); the company files dormant company accounts. Net assets were £100, up 100% on the previous year. Cash at bank and in hand was £100. Figures are available for 5 financial years (2020/21–2024/25).

How does it compare with similar companies?

Compared with 160,475 active companies whose first SIC code is 82990: It is older than 53% of them (median age 10.2 years).

Who runs and controls the company?

The company has 1 current director. One person with significant control is registered.

When are its next filings due?

The next accounts are due by 30 Dec 2026. The next confirmation statement is due by 19 Jan 2027.

Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand—6,8683,138—100
Total assets451,66663,05464,495——
Total liabilities258,684549,366822,431689,767—
Net assets / total equity192,982-146,152-469,444-689,767100
Average number of employees-8-18-20-10—

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

History

13 events
  1. Mr Angelos Pagonis ceased to be a person with significant control
  2. Angelos PAGONIS resignedDirector
  3. Financial year 2024/25 endedAccounts: net assets £100
  4. Financial year 2023/24 endedAccounts: net assets −£689.8k, -10 employees
  5. Financial year 2022/23 endedAccounts: net assets −£469.4k, -20 employees
  6. Financial year 2021/22 endedAccounts: net assets −£146.2k, -18 employees
  7. Financial year 2020/21 endedAccounts: net assets £193k, -8 employees
  8. Lydia Evgenia PAGONI appointedDirector
Earlier events (5)
  1. Miss Lydia Evgenia Pagoni registered as a person with significant control
  2. Mr Angelos Pagonis registered as a person with significant control
  3. Name changed to MOLECULAR IMAGING CONSULTING & MANAGEMENT LTDPreviously PAGONIS CONSULTING LTD
  4. Angelos PAGONIS appointedDirector
  5. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.